Your search returned 5 results.

Results
	1.	A CD20 tandem-epitope immunogen elicits antibody in mice that binds murine cell surface CD20 and depletes splenic B cells in vivo. [electronic resource] by Oscherwitz, Jon Gribbin, Thomas E Cease, Kemp B Producer: 20100422 In: Molecular immunology vol. 47 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Alveolar Rhabdomyosarcoma in a 69-Year-Old Woman Receiving Glucagon-Like Peptide-2 Therapy. [electronic resource] by Zyczynski, Laura E McHugh, Jonathan B Gribbin, Thomas E Schuetze, Scott M Producer: 20150812 In: Case reports in oncological medicine vol. 2015 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Effect of a Collaboration Between a Health Plan, Oncology Practice, and Comprehensive Genomic Profiling Company from the Payer Perspective. [electronic resource] by Reitsma, Mitchell Fox, John Borre, Pierre Vanden Cavanaugh, Matthew Chudnovsky, Yakov Erlich, Rachel L Gribbin, Thomas E Anhorn, Rachel Producer: 20190826 In: Journal of managed care & specialty pharmacy vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Early-phase clinical trials in the community: results from the national cancer institute community cancer centers program early-phase working group baseline assessment. [electronic resource] by Zaren, Howard A Nair, Suresh Go, Ronald S Enos, Rebecca A Lanier, Keith S Thompson, Michael A Zhao, Jinxiu Fleming, Deborah L Leighton, John C Gribbin, Thomas E Bryant, Donna M Carrigan, Angela Corpening, Jennifer C Csapo, Kimberly A Dimond, Eileen P Ellison, Christie Gonzalez, Maria M Harr, Jodi L Wilkinson, Kathy Denicoff, Andrea M Producer: 20131022 In: Journal of oncology practice vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies. [electronic resource] by Picozzi, Vincent J Ramanathan, Ramesh K Lowery, Maeve A Ocean, Allyson J Mitchel, Edith P O'Neil, Bert H Guarino, Michael J Conkling, Paul R Cohen, Steven J Bahary, Nathan Frank, Richard C Dragovich, Tomislav Bridges, Benjamin B Braiteh, Fadi S Starodub, Alexander N Lee, Fa-Chyi Gribbin, Thomas E Richards, Donald A Lee, Marie Korn, Ronald L Pandit-Taskar, Neeta Goldsmith, Stanley J Intenzo, Charles M Sheikh, Arif Manzone, Timothy C Horne, Heather Sharkey, Robert M Wegener, William A O'Reilly, Eileen M Goldenberg, David M Von Hoff, Daniel D Producer: 20151109 In: European journal of cancer (Oxford, England : 1990) vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)